195 related articles for article (PubMed ID: 10514112)
1. Comparison of assays for N-amino terminal propeptide of type III procollagen in chronic hepatitis C by using receiver operating characteristic analysis.
Walsh KM; Fletcher A; MacSween RN; Morris AJ
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):827-31. PubMed ID: 10514112
[TBL] [Abstract][Full Text] [Related]
2. Basement membrane peptides as markers of liver disease in chronic hepatitis C.
Walsh KM; Fletcher A; MacSween RN; Morris AJ
J Hepatol; 2000 Feb; 32(2):325-30. PubMed ID: 10707874
[TBL] [Abstract][Full Text] [Related]
3. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
4. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis.
Zheng M; Cai WM; Weng HL; Liu RH
World J Gastroenterol; 2002 Dec; 8(6):1073-6. PubMed ID: 12439928
[TBL] [Abstract][Full Text] [Related]
5. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
6. [Serum aminoterminal peptide of type III procollagen (PIIINP) and transforming growth factor-beta1 (TGF-beta1) levels in patients with chronic hepatitis B and C].
Marek B; Kajdaniuk D; Janczewska-Kazek E; Beniowski M; Swietochowska E; Kos-Kudła B; Ostrowska Z; Mazurek U; Wilczok T; Nowak M; Siemińska L; Borgiel-Marek H; Strzyzewski A; Januła A; Sierek K; Niedzielski Z
Pol Arch Med Wewn; 2003 Jun; 109(6):603-8. PubMed ID: 14567092
[TBL] [Abstract][Full Text] [Related]
7. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.
Murawaki Y; Ikuta Y; Okamoto K; Koda M; Kawasaki H
J Gastroenterol; 2001 Jun; 36(6):399-406. PubMed ID: 11428586
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease.
Frei A; Zimmermann A; Weigand K
Hepatology; 1984; 4(5):830-4. PubMed ID: 6479851
[TBL] [Abstract][Full Text] [Related]
10. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
11. Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III.
Serejo F; Costa A; Oliveira AG; Ramalho F; Batista A; De Moura MC
Dig Dis Sci; 2001 Aug; 46(8):1684-9. PubMed ID: 11508668
[TBL] [Abstract][Full Text] [Related]
12. Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease.
Mosca A; Comparcola D; Romito I; Mantovani A; Nobili V; Byrne CD; Alisi A; Targher G
Liver Int; 2019 Dec; 39(12):2317-2329. PubMed ID: 31436362
[TBL] [Abstract][Full Text] [Related]
13. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
14. Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase.
Liao Y; Gong J; Zhou W; Dong H; Liang J; Luo M; Hu B
J Med Virol; 2019 Apr; 91(4):642-649. PubMed ID: 30537157
[TBL] [Abstract][Full Text] [Related]
15. Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis.
Murawaki Y; Ikuta Y; Idobe Y; Kawasaki H
J Gastroenterol Hepatol; 1999 Feb; 14(2):138-45. PubMed ID: 10029294
[TBL] [Abstract][Full Text] [Related]
16. The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus.
Dong H; Xu C; Zhou W; Liao Y; Cao J; Li Z; Hu B
Clin Chim Acta; 2018 Aug; 483():145-150. PubMed ID: 29709450
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C.
Attallah AM; Toson EA; Shiha GE; Omran MM; Abdel-Aziz MM; El-Dosoky I
J Immunoassay Immunochem; 2007; 28(3):199-211. PubMed ID: 17613667
[TBL] [Abstract][Full Text] [Related]
18. Serum type I collagen propeptide and severity of alcoholic liver disease.
Niemelä O; Blake JE; Orrego H
Alcohol Clin Exp Res; 1992 Dec; 16(6):1064-7. PubMed ID: 1471760
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
20. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]